Cannabis Science, Inc. (OTC:CBIS) has traded as high as $.14 during today’s trading session and last traded at the high of the day for a gain of 9.52% from yesterday’s close… CBIS shares have traded as high as $.2455 over the past 52 weeks, which is 42.97% off that high at last traded stock price.
Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide new photographs of the existing treatment for patient three who has a “worst case” of treatment resistant, Squamous Cell Carcinoma. Cannabis Science has received positive feedback from both the patient and his Oncologist. These photos show the progressive reduction of the tumor masses that has occurred within the months of treatment. Get my next ALERT 100% FREE
Oncologists have stated that this is the worst case of squamous cell carcinoma, and last week, the patient’s oncologist said the results from the topical cannabis extract are “astonishing.” So instead of needing any surgery this month he is to go back and see the oncologist in June. The patient’s wife, who could not even look at her husband’s head months ago, has stated that it looks as if 75% of the tumors masses are gone.
Since Cannabis Science has been working with this patient extensively, Dr. Robert Melamede has provided lots of support and expert scientific advice during the treatment process. Patient three came to Cannabis Science with hope to find a treatment that would work. Due to his extremely severe case of squamous cell carcinoma, his surgeon wanted to remove his scalp and a good portion of his skull. Instead he opted for 135 radiation treatments, but the remaining tumors became radiation and chemotherapy resistant. Dr. Robert Melamede informs that, “Cannabis extracts have the unique ability to holistically improve health. They simultaneously modify numerous biochemical pathways to produces a healthy concerted action.”
You can view these new photos on the Cannabis Science website www.cannabisscience.com and click the button “View Images of 3rd Self-Medicated Patient & His Apparent Success.” You can read more news on this 3rd patient as well on the Cannabis Science website www.cannabisscience.com and click on the breaking news button where you will find all the cancer related and updated patient news.
About StockPreacher.com
StockPreacher.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.
StockPreacher Disclaimer
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockPreacher.com is a wholly owned subsidiary of BlueWave Advisors. BlueWave Advisors has not been compensated, and holds no positions in any of the stocks mentioned in this article.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
